{"transactions":[{"id":1698012,"issuer":{"id":95737,"kind":"organization","name":"Applied Molecular Transport Inc.","symbol":"AMTI"},"owners":[{"id":95738,"kind":"organization","name":"EPIQ Capital Group, LLC","position":1,"cik":"0001779453","reported_name":"EPIQ Capital Group, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Managing Member of 10% Owner"}},{"id":95739,"kind":"person","name":"Boeding Chad","position":2,"cik":"0001779451","reported_name":"Boeding Chad","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"CEO of Managing Member"}},{"id":95740,"kind":"organization","name":"EPQ LLC AMT PS","position":3,"cik":"0001751796","reported_name":"EPQ LLC AMT PS","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Owner"}},{"id":95741,"kind":"organization","name":"EPQ LLC, AMTB PS","position":4,"cik":"0001788890","reported_name":"EPQ LLC, AMTB PS","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"owner"}},{"id":95742,"kind":"organization","name":"EPQ LLC, AMTC PS","position":5,"cik":"0001814486","reported_name":"EPQ LLC, AMTC PS","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"owner"}}],"security":"Common Stock","published_at":"2023-12-29T17:40:35.000Z","date":"2023-12-27","kind":"other","planned":false,"acquired":false,"shares":293278,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On December 27, 2023, Applied Molecular Transport Inc. (\"AMTI\") completed the previously announced strategic combination contemplated by that certain Agreement and Plan of Merger, dated as of September 21, 2023, by and among Cyclo Therapeutics, Inc. (\"Cyclo\"), Cameo Merger Sub, Inc., a wholly owned subsidiary of Cyclo (\"Merger Sub\"), and AMTI, providing for the merger of Merger Sub with and into AMTI, with AMTI surviving the merger as a wholly-owned subsidiary of Cyclo (the \"Merger\"). At the Merger closing, each share of common stock of AMTI reported as disposed of on this Form 4 was automatically converted into the right to receive 0.1331 shares of common stock of Cyclo (the \"Transaction Consideration\"). Refer to the AMTI Form 8-K filing with the Securities and Exchange Commission dated December 27, 2023 for additional information concerning the Merger."},{"field":"shares","element":"transactionShares","label":"F5","text":"Chad Boeding is the owner of these shares through a trust that he controls."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Upon consummation of the Merger, Chad Boeding received Transaction Consideration of 39,036 shares of Cyclo common stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"EPIQ Capital Group, LLC (\"EPIQ\") is the managing member of EPQ LLC, AMT PS, EPQ LLC, AMTB PS, and EPQ LLC, AMTC PS (the \"EPQ Funds\"). Chad Boeding is the Manager of EPIQ."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001667731-23-000513","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1814486/000166773123000513/ownership.xml","form_type":"4"}},{"id":1698011,"issuer":{"id":95737,"kind":"organization","name":"Applied Molecular Transport Inc.","symbol":"AMTI"},"owners":[{"id":95738,"kind":"organization","name":"EPIQ Capital Group, LLC","position":1,"cik":"0001779453","reported_name":"EPIQ Capital Group, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Managing Member of 10% Owner"}},{"id":95739,"kind":"person","name":"Boeding Chad","position":2,"cik":"0001779451","reported_name":"Boeding Chad","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"CEO of Managing Member"}},{"id":95740,"kind":"organization","name":"EPQ LLC AMT PS","position":3,"cik":"0001751796","reported_name":"EPQ LLC AMT PS","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Owner"}},{"id":95741,"kind":"organization","name":"EPQ LLC, AMTB PS","position":4,"cik":"0001788890","reported_name":"EPQ LLC, AMTB PS","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"owner"}},{"id":95742,"kind":"organization","name":"EPQ LLC, AMTC PS","position":5,"cik":"0001814486","reported_name":"EPQ LLC, AMTC PS","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"owner"}}],"security":"Common Stock","published_at":"2023-12-29T17:40:35.000Z","date":"2023-12-27","kind":"other","planned":false,"acquired":false,"shares":2500000,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On December 27, 2023, Applied Molecular Transport Inc. (\"AMTI\") completed the previously announced strategic combination contemplated by that certain Agreement and Plan of Merger, dated as of September 21, 2023, by and among Cyclo Therapeutics, Inc. (\"Cyclo\"), Cameo Merger Sub, Inc., a wholly owned subsidiary of Cyclo (\"Merger Sub\"), and AMTI, providing for the merger of Merger Sub with and into AMTI, with AMTI surviving the merger as a wholly-owned subsidiary of Cyclo (the \"Merger\"). At the Merger closing, each share of common stock of AMTI reported as disposed of on this Form 4 was automatically converted into the right to receive 0.1331 shares of common stock of Cyclo (the \"Transaction Consideration\"). Refer to the AMTI Form 8-K filing with the Securities and Exchange Commission dated December 27, 2023 for additional information concerning the Merger."},{"field":"shares","element":"transactionShares","label":"F4","text":"EPQ LLC, AMTC PS is the direct owner of these shares."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Upon consummation of the Merger, EPQ LLC, AMTC PS received Transaction Consideration of 332,750 shares of Cyclo common stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"EPIQ Capital Group, LLC (\"EPIQ\") is the managing member of EPQ LLC, AMT PS, EPQ LLC, AMTB PS, and EPQ LLC, AMTC PS (the \"EPQ Funds\"). Chad Boeding is the Manager of EPIQ."}],"balance_after":293278,"source":{"system":"sec-edgar","filing":"0001667731-23-000513","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1814486/000166773123000513/ownership.xml","form_type":"4"}},{"id":1698010,"issuer":{"id":95737,"kind":"organization","name":"Applied Molecular Transport Inc.","symbol":"AMTI"},"owners":[{"id":95738,"kind":"organization","name":"EPIQ Capital Group, LLC","position":1,"cik":"0001779453","reported_name":"EPIQ Capital Group, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Managing Member of 10% Owner"}},{"id":95739,"kind":"person","name":"Boeding Chad","position":2,"cik":"0001779451","reported_name":"Boeding Chad","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"CEO of Managing Member"}},{"id":95740,"kind":"organization","name":"EPQ LLC AMT PS","position":3,"cik":"0001751796","reported_name":"EPQ LLC AMT PS","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Owner"}},{"id":95741,"kind":"organization","name":"EPQ LLC, AMTB PS","position":4,"cik":"0001788890","reported_name":"EPQ LLC, AMTB PS","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"owner"}},{"id":95742,"kind":"organization","name":"EPQ LLC, AMTC PS","position":5,"cik":"0001814486","reported_name":"EPQ LLC, AMTC PS","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"owner"}}],"security":"Common Stock","published_at":"2023-12-29T17:40:35.000Z","date":"2023-12-27","kind":"other","planned":false,"acquired":false,"shares":3394948,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On December 27, 2023, Applied Molecular Transport Inc. (\"AMTI\") completed the previously announced strategic combination contemplated by that certain Agreement and Plan of Merger, dated as of September 21, 2023, by and among Cyclo Therapeutics, Inc. (\"Cyclo\"), Cameo Merger Sub, Inc., a wholly owned subsidiary of Cyclo (\"Merger Sub\"), and AMTI, providing for the merger of Merger Sub with and into AMTI, with AMTI surviving the merger as a wholly-owned subsidiary of Cyclo (the \"Merger\"). At the Merger closing, each share of common stock of AMTI reported as disposed of on this Form 4 was automatically converted into the right to receive 0.1331 shares of common stock of Cyclo (the \"Transaction Consideration\"). Refer to the AMTI Form 8-K filing with the Securities and Exchange Commission dated December 27, 2023 for additional information concerning the Merger."},{"field":"shares","element":"transactionShares","label":"F3","text":"EPQ LLC, AMTB PS is the direct owner of these shares."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Upon consummation of the Merger, EPQ LLC, AMTB PS received Transaction Consideration of 451,868 shares of Cyclo common stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"EPIQ Capital Group, LLC (\"EPIQ\") is the managing member of EPQ LLC, AMT PS, EPQ LLC, AMTB PS, and EPQ LLC, AMTC PS (the \"EPQ Funds\"). Chad Boeding is the Manager of EPIQ."}],"balance_after":2793278,"source":{"system":"sec-edgar","filing":"0001667731-23-000513","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1814486/000166773123000513/ownership.xml","form_type":"4"}},{"id":1698009,"issuer":{"id":95737,"kind":"organization","name":"Applied Molecular Transport Inc.","symbol":"AMTI"},"owners":[{"id":95738,"kind":"organization","name":"EPIQ Capital Group, LLC","position":1,"cik":"0001779453","reported_name":"EPIQ Capital Group, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Managing Member of 10% Owner"}},{"id":95739,"kind":"person","name":"Boeding Chad","position":2,"cik":"0001779451","reported_name":"Boeding Chad","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"CEO of Managing Member"}},{"id":95740,"kind":"organization","name":"EPQ LLC AMT PS","position":3,"cik":"0001751796","reported_name":"EPQ LLC AMT PS","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Owner"}},{"id":95741,"kind":"organization","name":"EPQ LLC, AMTB PS","position":4,"cik":"0001788890","reported_name":"EPQ LLC, AMTB PS","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"owner"}},{"id":95742,"kind":"organization","name":"EPQ LLC, AMTC PS","position":5,"cik":"0001814486","reported_name":"EPQ LLC, AMTC PS","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"owner"}}],"security":"Common Stock","published_at":"2023-12-29T17:40:35.000Z","date":"2023-12-27","kind":"other","planned":false,"acquired":false,"shares":2149292,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On December 27, 2023, Applied Molecular Transport Inc. (\"AMTI\") completed the previously announced strategic combination contemplated by that certain Agreement and Plan of Merger, dated as of September 21, 2023, by and among Cyclo Therapeutics, Inc. (\"Cyclo\"), Cameo Merger Sub, Inc., a wholly owned subsidiary of Cyclo (\"Merger Sub\"), and AMTI, providing for the merger of Merger Sub with and into AMTI, with AMTI surviving the merger as a wholly-owned subsidiary of Cyclo (the \"Merger\"). At the Merger closing, each share of common stock of AMTI reported as disposed of on this Form 4 was automatically converted into the right to receive 0.1331 shares of common stock of Cyclo (the \"Transaction Consideration\"). Refer to the AMTI Form 8-K filing with the Securities and Exchange Commission dated December 27, 2023 for additional information concerning the Merger."},{"field":"shares","element":"transactionShares","label":"F2","text":"EPQ LLC, AMT PS is the direct owner of these shares."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Upon consummation of the Merger, EPQ LLC, AMT PS received Transaction Consideration of 286,071 shares of Cyclo common stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"EPIQ Capital Group, LLC (\"EPIQ\") is the managing member of EPQ LLC, AMT PS, EPQ LLC, AMTB PS, and EPQ LLC, AMTC PS (the \"EPQ Funds\"). Chad Boeding is the Manager of EPIQ."}],"balance_after":6188226,"source":{"system":"sec-edgar","filing":"0001667731-23-000513","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814486/000166773123000513/ownership.xml","form_type":"4"}},{"id":2083888,"issuer":{"id":115613,"kind":"organization","name":"Lucira Health, Inc.","symbol":"LHDX"},"owners":[{"id":95738,"kind":"organization","name":"EPIQ Capital Group, LLC","position":1,"cik":"0001779453","reported_name":"EPIQ Capital Group, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":121534,"kind":"organization","name":"EPQ LLC, LTEST PS","position":2,"cik":"0001841495","reported_name":"EPQ LLC, LTEST PS","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Less than 10% Owner"}},{"id":121535,"kind":"organization","name":"EPQ LLC, LFLU PS","position":3,"cik":"0001798799","reported_name":"EPQ LLC, LFLU PS","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Less than 10% owner"}},{"id":121536,"kind":"organization","name":"EPQ LLC, LCOVD PS","position":4,"cik":"0001818376","reported_name":"EPQ LLC, LCOVD PS","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":121537,"kind":"organization","name":"EPQ LLC, LCOVD SAFE PS","position":5,"cik":"0001833912","reported_name":"EPQ LLC, LCOVD SAFE PS","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Less than 10% owner"}},{"id":95739,"kind":"person","name":"Boeding Chad","position":6,"cik":"0001779451","reported_name":"Boeding Chad","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"CEO of 10% owner"}}],"security":"Common Stock","published_at":"2022-12-16T17:38:13.000Z","date":"2022-12-14","kind":"other","acquired":true,"shares":725675,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On December 14, 2022, EPQ LLC, LTEST PS (\"LTEST\") distributed, for no consideration, in the aggregate 3,461,764 shares of the Issuer's Common Stock (the \"LTEST Shares\") to its members, representing each such member's pro rata interest in such LTEST Shares. All of the aforementioned distributions were made in accordance with the exemptions afforded by Rules 16a-13 and 16a-9 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\")."},{"field":"kind","element":"transactionCoding","label":"F3","text":"On December 14, 2022, EPQ LLC, LFLU PS (\"LFLU\") distributed, for no consideration, in the aggregate 3,754,084 shares of the Issuer's Common Stock (the \"LFLU Shares\") to its members, representing each such member's pro rata interest in such LFLU Shares. All of the aforementioned distributions were made in accordance with the exemptions afforded by Rules 16a-13 and 16a-9 of the Exchange Act."},{"field":"kind","element":"transactionCoding","label":"F5","text":"On December 14, 2022, EPQ LLC, LCOVD PS (\"LCOVD\") distributed, for no consideration, in the aggregate 5,5173,026 shares of the Issuer's Common Stock (the \"LCOVD Shares\") to its members, representing each such member's pro rata interest in such LCOVD Shares. All of the aforementioned distributions were made in accordance with the exemptions afforded by Rules 16a-13 and 16a-9 of the Exchange Act."},{"field":"kind","element":"transactionCoding","label":"F7","text":"On December 14, 2022, EPQ LLC, LCOVD SAFE PS (\"SAFE\") distributed, for no consideration, in the aggregate 735,475 shares of the Issuer's Common Stock (the \"SAFE Shares\") to its members, representing each such member's pro rata interest in such SAFE Shares. All of the aforementioned distributions were made in accordance with the exemptions afforded by Rules 16a-13 and 16a-9 of the Exchange Act."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On December 14, 2022, EPQ LLC, LTEST PS (\"LTEST\") distributed, for no consideration, in the aggregate 3,461,764 shares of the Issuer's Common Stock (the \"LTEST Shares\") to its members, representing each such member's pro rata interest in such LTEST Shares. All of the aforementioned distributions were made in accordance with the exemptions afforded by Rules 16a-13 and 16a-9 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\")."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On December 14, 2022, EPQ LLC, LFLU PS (\"LFLU\") distributed, for no consideration, in the aggregate 3,754,084 shares of the Issuer's Common Stock (the \"LFLU Shares\") to its members, representing each such member's pro rata interest in such LFLU Shares. All of the aforementioned distributions were made in accordance with the exemptions afforded by Rules 16a-13 and 16a-9 of the Exchange Act."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"On December 14, 2022, EPQ LLC, LCOVD PS (\"LCOVD\") distributed, for no consideration, in the aggregate 5,5173,026 shares of the Issuer's Common Stock (the \"LCOVD Shares\") to its members, representing each such member's pro rata interest in such LCOVD Shares. All of the aforementioned distributions were made in accordance with the exemptions afforded by Rules 16a-13 and 16a-9 of the Exchange Act."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"On December 14, 2022, EPQ LLC, LCOVD SAFE PS (\"SAFE\") distributed, for no consideration, in the aggregate 735,475 shares of the Issuer's Common Stock (the \"SAFE Shares\") to its members, representing each such member's pro rata interest in such SAFE Shares. All of the aforementioned distributions were made in accordance with the exemptions afforded by Rules 16a-13 and 16a-9 of the Exchange Act."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F10","text":"The shares are held by entities under control of EPIQ Capital Group, LLC (\"EPIQ\"). None of the reporting persons has any pecuniary interest in these shares."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F11","text":"The reporting persons are EPIQ, Chad Boeding, LFLU, LCOVD, SAFE, and LTEST. EPIQ is the managing member of and LFLU, LCOVD, SAFE, and LTEST. Mr. Boeding is the CEO and Manager of EPIQ. EPIQ is filing this Form 4 on behalf of the reporting persons jointly, but not as a group. EPIQ, LFLU, LCOVD, SAFE, LTEST and Mr. Boeding each disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Exchange Act except to the extent of its or his pecuniary interest therein, if any. This report shall not be deemed an admission that any of the Reporting Persons is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"The shares are held by entities under control of EPIQ Capital Group, LLC (\"EPIQ\"). None of the reporting persons has any pecuniary interest in these shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F11","text":"The reporting persons are EPIQ, Chad Boeding, LFLU, LCOVD, SAFE, and LTEST. EPIQ is the managing member of and LFLU, LCOVD, SAFE, and LTEST. Mr. Boeding is the CEO and Manager of EPIQ. EPIQ is filing this Form 4 on behalf of the reporting persons jointly, but not as a group. EPIQ, LFLU, LCOVD, SAFE, LTEST and Mr. Boeding each disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Exchange Act except to the extent of its or his pecuniary interest therein, if any. This report shall not be deemed an admission that any of the Reporting Persons is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose."}],"balance_after":1014593,"source":{"system":"sec-edgar","filing":"0001667731-22-000447","document":"s202212lhdxform4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1818376/000166773122000447/s202212lhdxform4.xml","form_type":"4"}},{"id":2083887,"issuer":{"id":115613,"kind":"organization","name":"Lucira Health, Inc.","symbol":"LHDX"},"owners":[{"id":95738,"kind":"organization","name":"EPIQ Capital Group, LLC","position":1,"cik":"0001779453","reported_name":"EPIQ Capital Group, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":121534,"kind":"organization","name":"EPQ LLC, LTEST PS","position":2,"cik":"0001841495","reported_name":"EPQ LLC, LTEST PS","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Less than 10% Owner"}},{"id":121535,"kind":"organization","name":"EPQ LLC, LFLU PS","position":3,"cik":"0001798799","reported_name":"EPQ LLC, LFLU PS","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Less than 10% owner"}},{"id":121536,"kind":"organization","name":"EPQ LLC, LCOVD PS","position":4,"cik":"0001818376","reported_name":"EPQ LLC, LCOVD PS","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":121537,"kind":"organization","name":"EPQ LLC, LCOVD SAFE PS","position":5,"cik":"0001833912","reported_name":"EPQ LLC, LCOVD SAFE PS","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Less than 10% owner"}},{"id":95739,"kind":"person","name":"Boeding Chad","position":6,"cik":"0001779451","reported_name":"Boeding Chad","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"CEO of 10% owner"}}],"security":"Common Stock","published_at":"2022-12-16T17:38:13.000Z","date":"2022-12-14","kind":"other","acquired":true,"shares":256742,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On December 14, 2022, EPQ LLC, LTEST PS (\"LTEST\") distributed, for no consideration, in the aggregate 3,461,764 shares of the Issuer's Common Stock (the \"LTEST Shares\") to its members, representing each such member's pro rata interest in such LTEST Shares. All of the aforementioned distributions were made in accordance with the exemptions afforded by Rules 16a-13 and 16a-9 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\")."},{"field":"kind","element":"transactionCoding","label":"F3","text":"On December 14, 2022, EPQ LLC, LFLU PS (\"LFLU\") distributed, for no consideration, in the aggregate 3,754,084 shares of the Issuer's Common Stock (the \"LFLU Shares\") to its members, representing each such member's pro rata interest in such LFLU Shares. All of the aforementioned distributions were made in accordance with the exemptions afforded by Rules 16a-13 and 16a-9 of the Exchange Act."},{"field":"kind","element":"transactionCoding","label":"F5","text":"On December 14, 2022, EPQ LLC, LCOVD PS (\"LCOVD\") distributed, for no consideration, in the aggregate 5,5173,026 shares of the Issuer's Common Stock (the \"LCOVD Shares\") to its members, representing each such member's pro rata interest in such LCOVD Shares. All of the aforementioned distributions were made in accordance with the exemptions afforded by Rules 16a-13 and 16a-9 of the Exchange Act."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On December 14, 2022, EPQ LLC, LTEST PS (\"LTEST\") distributed, for no consideration, in the aggregate 3,461,764 shares of the Issuer's Common Stock (the \"LTEST Shares\") to its members, representing each such member's pro rata interest in such LTEST Shares. All of the aforementioned distributions were made in accordance with the exemptions afforded by Rules 16a-13 and 16a-9 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\")."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On December 14, 2022, EPQ LLC, LFLU PS (\"LFLU\") distributed, for no consideration, in the aggregate 3,754,084 shares of the Issuer's Common Stock (the \"LFLU Shares\") to its members, representing each such member's pro rata interest in such LFLU Shares. All of the aforementioned distributions were made in accordance with the exemptions afforded by Rules 16a-13 and 16a-9 of the Exchange Act."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"On December 14, 2022, EPQ LLC, LCOVD PS (\"LCOVD\") distributed, for no consideration, in the aggregate 5,5173,026 shares of the Issuer's Common Stock (the \"LCOVD Shares\") to its members, representing each such member's pro rata interest in such LCOVD Shares. All of the aforementioned distributions were made in accordance with the exemptions afforded by Rules 16a-13 and 16a-9 of the Exchange Act."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F9","text":"The shares are held directly by Chad Boeding (2,941), a trust of which Mr. Boeding is the trustee and beneficial owner (161,949 shares), and a limited liability company of which Mr. Boeding is the managing member (91,852 shares)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"The shares are held directly by Chad Boeding (2,941), a trust of which Mr. Boeding is the trustee and beneficial owner (161,949 shares), and a limited liability company of which Mr. Boeding is the managing member (91,852 shares)."}],"balance_after":288918,"source":{"system":"sec-edgar","filing":"0001667731-22-000447","document":"s202212lhdxform4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1818376/000166773122000447/s202212lhdxform4.xml","form_type":"4"}},{"id":2083886,"issuer":{"id":115613,"kind":"organization","name":"Lucira Health, Inc.","symbol":"LHDX"},"owners":[{"id":95738,"kind":"organization","name":"EPIQ Capital Group, LLC","position":1,"cik":"0001779453","reported_name":"EPIQ Capital Group, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":121534,"kind":"organization","name":"EPQ LLC, LTEST PS","position":2,"cik":"0001841495","reported_name":"EPQ LLC, LTEST PS","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Less than 10% Owner"}},{"id":121535,"kind":"organization","name":"EPQ LLC, LFLU PS","position":3,"cik":"0001798799","reported_name":"EPQ LLC, LFLU PS","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Less than 10% owner"}},{"id":121536,"kind":"organization","name":"EPQ LLC, LCOVD PS","position":4,"cik":"0001818376","reported_name":"EPQ LLC, LCOVD PS","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":121537,"kind":"organization","name":"EPQ LLC, LCOVD SAFE PS","position":5,"cik":"0001833912","reported_name":"EPQ LLC, LCOVD SAFE PS","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Less than 10% owner"}},{"id":95739,"kind":"person","name":"Boeding Chad","position":6,"cik":"0001779451","reported_name":"Boeding Chad","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"CEO of 10% owner"}}],"security":"Common Stock","published_at":"2022-12-16T17:38:13.000Z","date":"2022-12-14","kind":"other","acquired":false,"shares":735475,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F7","text":"On December 14, 2022, EPQ LLC, LCOVD SAFE PS (\"SAFE\") distributed, for no consideration, in the aggregate 735,475 shares of the Issuer's Common Stock (the \"SAFE Shares\") to its members, representing each such member's pro rata interest in such SAFE Shares. All of the aforementioned distributions were made in accordance with the exemptions afforded by Rules 16a-13 and 16a-9 of the Exchange Act."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"On December 14, 2022, EPQ LLC, LCOVD SAFE PS (\"SAFE\") distributed, for no consideration, in the aggregate 735,475 shares of the Issuer's Common Stock (the \"SAFE Shares\") to its members, representing each such member's pro rata interest in such SAFE Shares. All of the aforementioned distributions were made in accordance with the exemptions afforded by Rules 16a-13 and 16a-9 of the Exchange Act."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F8","text":"SAFE is the direct beneficial owner of these shares."}],"balance_after":32176,"source":{"system":"sec-edgar","filing":"0001667731-22-000447","document":"s202212lhdxform4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1818376/000166773122000447/s202212lhdxform4.xml","form_type":"4"}},{"id":2083885,"issuer":{"id":115613,"kind":"organization","name":"Lucira Health, Inc.","symbol":"LHDX"},"owners":[{"id":95738,"kind":"organization","name":"EPIQ Capital Group, LLC","position":1,"cik":"0001779453","reported_name":"EPIQ Capital Group, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":121534,"kind":"organization","name":"EPQ LLC, LTEST PS","position":2,"cik":"0001841495","reported_name":"EPQ LLC, LTEST PS","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Less than 10% Owner"}},{"id":121535,"kind":"organization","name":"EPQ LLC, LFLU PS","position":3,"cik":"0001798799","reported_name":"EPQ LLC, LFLU PS","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Less than 10% owner"}},{"id":121536,"kind":"organization","name":"EPQ LLC, LCOVD PS","position":4,"cik":"0001818376","reported_name":"EPQ LLC, LCOVD PS","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":121537,"kind":"organization","name":"EPQ LLC, LCOVD SAFE PS","position":5,"cik":"0001833912","reported_name":"EPQ LLC, LCOVD SAFE PS","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Less than 10% owner"}},{"id":95739,"kind":"person","name":"Boeding Chad","position":6,"cik":"0001779451","reported_name":"Boeding Chad","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"CEO of 10% owner"}}],"security":"Common Stock","published_at":"2022-12-16T17:38:13.000Z","date":"2022-12-14","kind":"other","acquired":false,"shares":5173026,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"On December 14, 2022, EPQ LLC, LCOVD PS (\"LCOVD\") distributed, for no consideration, in the aggregate 5,5173,026 shares of the Issuer's Common Stock (the \"LCOVD Shares\") to its members, representing each such member's pro rata interest in such LCOVD Shares. All of the aforementioned distributions were made in accordance with the exemptions afforded by Rules 16a-13 and 16a-9 of the Exchange Act."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"On December 14, 2022, EPQ LLC, LCOVD PS (\"LCOVD\") distributed, for no consideration, in the aggregate 5,5173,026 shares of the Issuer's Common Stock (the \"LCOVD Shares\") to its members, representing each such member's pro rata interest in such LCOVD Shares. All of the aforementioned distributions were made in accordance with the exemptions afforded by Rules 16a-13 and 16a-9 of the Exchange Act."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F6","text":"LCOVD is the direct beneficial owner of these shares."}],"balance_after":767651,"source":{"system":"sec-edgar","filing":"0001667731-22-000447","document":"s202212lhdxform4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1818376/000166773122000447/s202212lhdxform4.xml","form_type":"4"}},{"id":2083884,"issuer":{"id":115613,"kind":"organization","name":"Lucira Health, Inc.","symbol":"LHDX"},"owners":[{"id":95738,"kind":"organization","name":"EPIQ Capital Group, LLC","position":1,"cik":"0001779453","reported_name":"EPIQ Capital Group, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":121534,"kind":"organization","name":"EPQ LLC, LTEST PS","position":2,"cik":"0001841495","reported_name":"EPQ LLC, LTEST PS","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Less than 10% Owner"}},{"id":121535,"kind":"organization","name":"EPQ LLC, LFLU PS","position":3,"cik":"0001798799","reported_name":"EPQ LLC, LFLU PS","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Less than 10% owner"}},{"id":121536,"kind":"organization","name":"EPQ LLC, LCOVD PS","position":4,"cik":"0001818376","reported_name":"EPQ LLC, LCOVD PS","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":121537,"kind":"organization","name":"EPQ LLC, LCOVD SAFE PS","position":5,"cik":"0001833912","reported_name":"EPQ LLC, LCOVD SAFE PS","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Less than 10% owner"}},{"id":95739,"kind":"person","name":"Boeding Chad","position":6,"cik":"0001779451","reported_name":"Boeding Chad","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"CEO of 10% owner"}}],"security":"Common Stock","published_at":"2022-12-16T17:38:13.000Z","date":"2022-12-14","kind":"other","acquired":false,"shares":3754084,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"On December 14, 2022, EPQ LLC, LFLU PS (\"LFLU\") distributed, for no consideration, in the aggregate 3,754,084 shares of the Issuer's Common Stock (the \"LFLU Shares\") to its members, representing each such member's pro rata interest in such LFLU Shares. All of the aforementioned distributions were made in accordance with the exemptions afforded by Rules 16a-13 and 16a-9 of the Exchange Act."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On December 14, 2022, EPQ LLC, LFLU PS (\"LFLU\") distributed, for no consideration, in the aggregate 3,754,084 shares of the Issuer's Common Stock (the \"LFLU Shares\") to its members, representing each such member's pro rata interest in such LFLU Shares. All of the aforementioned distributions were made in accordance with the exemptions afforded by Rules 16a-13 and 16a-9 of the Exchange Act."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"LFLU is the direct beneficial owner of these shares."}],"balance_after":5940677,"source":{"system":"sec-edgar","filing":"0001667731-22-000447","document":"s202212lhdxform4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1818376/000166773122000447/s202212lhdxform4.xml","form_type":"4"}},{"id":2083883,"issuer":{"id":115613,"kind":"organization","name":"Lucira Health, Inc.","symbol":"LHDX"},"owners":[{"id":95738,"kind":"organization","name":"EPIQ Capital Group, LLC","position":1,"cik":"0001779453","reported_name":"EPIQ Capital Group, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":121534,"kind":"organization","name":"EPQ LLC, LTEST PS","position":2,"cik":"0001841495","reported_name":"EPQ LLC, LTEST PS","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Less than 10% Owner"}},{"id":121535,"kind":"organization","name":"EPQ LLC, LFLU PS","position":3,"cik":"0001798799","reported_name":"EPQ LLC, LFLU PS","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Less than 10% owner"}},{"id":121536,"kind":"organization","name":"EPQ LLC, LCOVD PS","position":4,"cik":"0001818376","reported_name":"EPQ LLC, LCOVD PS","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":121537,"kind":"organization","name":"EPQ LLC, LCOVD SAFE PS","position":5,"cik":"0001833912","reported_name":"EPQ LLC, LCOVD SAFE PS","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Less than 10% owner"}},{"id":95739,"kind":"person","name":"Boeding Chad","position":6,"cik":"0001779451","reported_name":"Boeding Chad","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"CEO of 10% owner"}}],"security":"Common Stock","published_at":"2022-12-16T17:38:13.000Z","date":"2022-12-14","kind":"other","acquired":false,"shares":3461764,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On December 14, 2022, EPQ LLC, LTEST PS (\"LTEST\") distributed, for no consideration, in the aggregate 3,461,764 shares of the Issuer's Common Stock (the \"LTEST Shares\") to its members, representing each such member's pro rata interest in such LTEST Shares. All of the aforementioned distributions were made in accordance with the exemptions afforded by Rules 16a-13 and 16a-9 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\")."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On December 14, 2022, EPQ LLC, LTEST PS (\"LTEST\") distributed, for no consideration, in the aggregate 3,461,764 shares of the Issuer's Common Stock (the \"LTEST Shares\") to its members, representing each such member's pro rata interest in such LTEST Shares. All of the aforementioned distributions were made in accordance with the exemptions afforded by Rules 16a-13 and 16a-9 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\")."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"LTEST is the direct beneficial owner of these shares."}],"balance_after":9694761,"source":{"system":"sec-edgar","filing":"0001667731-22-000447","document":"s202212lhdxform4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818376/000166773122000447/s202212lhdxform4.xml","form_type":"4"}},{"id":2270493,"issuer":{"id":95737,"kind":"organization","name":"Applied Molecular Transport Inc.","symbol":"AMTI"},"owners":[{"id":95738,"kind":"organization","name":"EPIQ Capital Group, LLC","position":1,"cik":"0001779453","reported_name":"EPIQ Capital Group, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Managing Member of 10% Owner"}},{"id":95740,"kind":"organization","name":"EPQ LLC AMT PS","position":2,"cik":"0001751796","reported_name":"EPQ LLC AMT PS","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Owner"}},{"id":95741,"kind":"organization","name":"EPQ LLC, AMTB PS","position":3,"cik":"0001788890","reported_name":"EPQ LLC, AMTB PS","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Owner"}},{"id":95742,"kind":"organization","name":"EPQ LLC, AMTC PS","position":4,"cik":"0001814486","reported_name":"EPQ LLC, AMTC PS","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Owner"}},{"id":95739,"kind":"person","name":"Boeding Chad","position":5,"cik":"0001779451","reported_name":"Boeding Chad","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"CEO of Managing Member"}}],"security":"Common Stock","published_at":"2022-05-16T17:49:40.000Z","date":"2022-05-13","kind":"purchase","acquired":true,"shares":29763,"price":4.1704,"value":124123.6152,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Chad Boeding acquired the shares listed in column 4 through a trust that he controls."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"EPIQ Capital Group, LLC (\"EPIQ\") is the managing member of EPQ LLC, AMT PS, EPQ LLC, AMTB PS, and EPQ LLC, AMTC PS (the \"EPQ Funds\"). Chad Boeding is the Manager of EPIQ. EPQ LLC, AMT PS directly owns 2,149,292 common shares. EPQ LLC, AMTB PS directly owns 3,394,948 common shares. EPQ LLC, AMTC PS directly owns 2,500,000 common shares. Chad Boeding owns 293,278 common shares through a trust that he controls."}],"balance_after":8337518,"source":{"system":"sec-edgar","filing":"0001667731-22-000196","document":"s202205epiqamti.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1814486/000166773122000196/s202205epiqamti.xml","form_type":"4"}},{"id":2270492,"issuer":{"id":95737,"kind":"organization","name":"Applied Molecular Transport Inc.","symbol":"AMTI"},"owners":[{"id":95738,"kind":"organization","name":"EPIQ Capital Group, LLC","position":1,"cik":"0001779453","reported_name":"EPIQ Capital Group, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Managing Member of 10% Owner"}},{"id":95740,"kind":"organization","name":"EPQ LLC AMT PS","position":2,"cik":"0001751796","reported_name":"EPQ LLC AMT PS","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Owner"}},{"id":95741,"kind":"organization","name":"EPQ LLC, AMTB PS","position":3,"cik":"0001788890","reported_name":"EPQ LLC, AMTB PS","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Owner"}},{"id":95742,"kind":"organization","name":"EPQ LLC, AMTC PS","position":4,"cik":"0001814486","reported_name":"EPQ LLC, AMTC PS","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Owner"}},{"id":95739,"kind":"person","name":"Boeding Chad","position":5,"cik":"0001779451","reported_name":"Boeding Chad","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"CEO of Managing Member"}}],"security":"Common Stock","published_at":"2022-05-16T17:49:40.000Z","date":"2022-05-12","kind":"purchase","acquired":true,"shares":32380,"price":3.88,"value":125634.4,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Chad Boeding acquired the shares listed in column 4 through a trust that he controls."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"EPIQ Capital Group, LLC (\"EPIQ\") is the managing member of EPQ LLC, AMT PS, EPQ LLC, AMTB PS, and EPQ LLC, AMTC PS (the \"EPQ Funds\"). Chad Boeding is the Manager of EPIQ. EPQ LLC, AMT PS directly owns 2,149,292 common shares. EPQ LLC, AMTB PS directly owns 3,394,948 common shares. EPQ LLC, AMTC PS directly owns 2,500,000 common shares. Chad Boeding owns 293,278 common shares through a trust that he controls."}],"balance_after":8307755,"source":{"system":"sec-edgar","filing":"0001667731-22-000196","document":"s202205epiqamti.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814486/000166773122000196/s202205epiqamti.xml","form_type":"4"}},{"id":2872396,"issuer":{"id":115613,"kind":"organization","name":"Lucira Health, Inc.","symbol":"LHDX"},"owners":[{"id":95738,"kind":"organization","name":"EPIQ Capital Group, LLC","position":1,"cik":"0001779453","reported_name":"EPIQ Capital Group, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":121535,"kind":"organization","name":"EPQ LLC, LFLU PS","position":2,"cik":"0001798799","reported_name":"EPQ LLC, LFLU PS","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"<10% Owner"}},{"id":121536,"kind":"organization","name":"EPQ LLC, LCOVD PS","position":3,"cik":"0001818376","reported_name":"EPQ LLC, LCOVD PS","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":121537,"kind":"organization","name":"EPQ LLC, LCOVD SAFE PS","position":4,"cik":"0001833912","reported_name":"EPQ LLC, LCOVD SAFE PS","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"<10% Owner"}},{"id":121534,"kind":"organization","name":"EPQ LLC, LTEST PS","position":5,"cik":"0001841495","reported_name":"EPQ LLC, LTEST PS","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"<10% Owner"}},{"id":95739,"kind":"person","name":"Boeding Chad","position":6,"cik":"0001779451","reported_name":"Boeding Chad","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"CEO of 10% Owner"}}],"security":"2020B Convertible Promissory Note","published_at":"2021-02-09T18:39:06.000Z","date":"2021-02-05","kind":"exercise","acquired":false,"shares":735475,"price":17,"value":12503075.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The convertible promissory note automatically converted into shares of the Issuer's Common Stock upon the closing of the IPO."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The convertible promissory note automatically converted into shares of the Issuer's Common Stock upon the closing of the IPO."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The convertible promissory note automatically converted into shares of the Issuer's Common Stock upon the closing of the IPO."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F6","text":"EPQ LLC, LCOVD SAFE PS (\"SAFE\") is the direct beneficial owner of this shares."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F8","text":"EPIQ Capital Group, LLC (\"EPIQ\") may be deemed an indirect beneficial owner of 13,124,349 shares of Issuer's Common Stock, which are held by LFLU (3,754,084 shares), LCOVD (5,173,026 shares), SAFE (735,475 shares), and LTEST (3,461,764 shares)."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F9","text":"The reporting persons are EPIQ, Chad Boeding, LFLU, LCOVD, SAFE, and LTEST. EPIQ is the managing member of and LFLU, LCOVD, SAFE, and LTEST. Mr. Boeding is the CEO and Manager of EPIQ. EPIQ is filing this Form 4 on behalf of the reporting persons jointly, but not as a group. LFLU, LCOVD, SAFE, LTEST and Mr. Boeding each disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934 except to the extent of its or his pecuniary interest therein, if any. This report shall not be deemed an admission that any of the Reporting Persons is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose."}],"balance_after":0,"derivative":{"expiration_date":"2022-12-11","underlying":"Common Stock","underlying_shares":735475},"source":{"system":"sec-edgar","filing":"0001779453-21-000004","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1818376/000177945321000004/primary_doc.xml","form_type":"4"}},{"id":2872395,"issuer":{"id":115613,"kind":"organization","name":"Lucira Health, Inc.","symbol":"LHDX"},"owners":[{"id":95738,"kind":"organization","name":"EPIQ Capital Group, LLC","position":1,"cik":"0001779453","reported_name":"EPIQ Capital Group, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":121535,"kind":"organization","name":"EPQ LLC, LFLU PS","position":2,"cik":"0001798799","reported_name":"EPQ LLC, LFLU PS","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"<10% Owner"}},{"id":121536,"kind":"organization","name":"EPQ LLC, LCOVD PS","position":3,"cik":"0001818376","reported_name":"EPQ LLC, LCOVD PS","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":121537,"kind":"organization","name":"EPQ LLC, LCOVD SAFE PS","position":4,"cik":"0001833912","reported_name":"EPQ LLC, LCOVD SAFE PS","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"<10% Owner"}},{"id":121534,"kind":"organization","name":"EPQ LLC, LTEST PS","position":5,"cik":"0001841495","reported_name":"EPQ LLC, LTEST PS","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"<10% Owner"}},{"id":95739,"kind":"person","name":"Boeding Chad","position":6,"cik":"0001779451","reported_name":"Boeding Chad","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"CEO of 10% Owner"}}],"security":"Series C Convertible Preferred","published_at":"2021-02-09T18:39:06.000Z","date":"2021-02-05","kind":"exercise","acquired":false,"shares":5173026,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series B Preferred Stock and Series C Preferred Stock (the \"Preferred Stock\") automatically converted on a one-for-one basis into Common Stock upon the closing of the Issuer's initial public offering (the \"IPO\"), for no additional consideration. The shares of Preferred Stock have no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series B Preferred Stock and Series C Preferred Stock (the \"Preferred Stock\") automatically converted on a one-for-one basis into Common Stock upon the closing of the Issuer's initial public offering (the \"IPO\"), for no additional consideration. The shares of Preferred Stock have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series B Preferred Stock and Series C Preferred Stock (the \"Preferred Stock\") automatically converted on a one-for-one basis into Common Stock upon the closing of the Issuer's initial public offering (the \"IPO\"), for no additional consideration. The shares of Preferred Stock have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series B Preferred Stock and Series C Preferred Stock (the \"Preferred Stock\") automatically converted on a one-for-one basis into Common Stock upon the closing of the Issuer's initial public offering (the \"IPO\"), for no additional consideration. The shares of Preferred Stock have no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"EPQ LLC, LCOVD PS (\"LCOVD\") is the direct beneficial owner of these shares."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F8","text":"EPIQ Capital Group, LLC (\"EPIQ\") may be deemed an indirect beneficial owner of 13,124,349 shares of Issuer's Common Stock, which are held by LFLU (3,754,084 shares), LCOVD (5,173,026 shares), SAFE (735,475 shares), and LTEST (3,461,764 shares)."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F9","text":"The reporting persons are EPIQ, Chad Boeding, LFLU, LCOVD, SAFE, and LTEST. EPIQ is the managing member of and LFLU, LCOVD, SAFE, and LTEST. Mr. Boeding is the CEO and Manager of EPIQ. EPIQ is filing this Form 4 on behalf of the reporting persons jointly, but not as a group. LFLU, LCOVD, SAFE, LTEST and Mr. Boeding each disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934 except to the extent of its or his pecuniary interest therein, if any. This report shall not be deemed an admission that any of the Reporting Persons is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":5173026},"source":{"system":"sec-edgar","filing":"0001779453-21-000004","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1818376/000177945321000004/primary_doc.xml","form_type":"4"}},{"id":2872394,"issuer":{"id":115613,"kind":"organization","name":"Lucira Health, Inc.","symbol":"LHDX"},"owners":[{"id":95738,"kind":"organization","name":"EPIQ Capital Group, LLC","position":1,"cik":"0001779453","reported_name":"EPIQ Capital Group, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":121535,"kind":"organization","name":"EPQ LLC, LFLU PS","position":2,"cik":"0001798799","reported_name":"EPQ LLC, LFLU PS","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"<10% Owner"}},{"id":121536,"kind":"organization","name":"EPQ LLC, LCOVD PS","position":3,"cik":"0001818376","reported_name":"EPQ LLC, LCOVD PS","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":121537,"kind":"organization","name":"EPQ LLC, LCOVD SAFE PS","position":4,"cik":"0001833912","reported_name":"EPQ LLC, LCOVD SAFE PS","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"<10% Owner"}},{"id":121534,"kind":"organization","name":"EPQ LLC, LTEST PS","position":5,"cik":"0001841495","reported_name":"EPQ LLC, LTEST PS","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"<10% Owner"}},{"id":95739,"kind":"person","name":"Boeding Chad","position":6,"cik":"0001779451","reported_name":"Boeding Chad","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"CEO of 10% Owner"}}],"security":"Series B Convertible Preferred","published_at":"2021-02-09T18:39:06.000Z","date":"2021-02-05","kind":"exercise","acquired":false,"shares":3754084,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series B Preferred Stock and Series C Preferred Stock (the \"Preferred Stock\") automatically converted on a one-for-one basis into Common Stock upon the closing of the Issuer's initial public offering (the \"IPO\"), for no additional consideration. The shares of Preferred Stock have no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series B Preferred Stock and Series C Preferred Stock (the \"Preferred Stock\") automatically converted on a one-for-one basis into Common Stock upon the closing of the Issuer's initial public offering (the \"IPO\"), for no additional consideration. The shares of Preferred Stock have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series B Preferred Stock and Series C Preferred Stock (the \"Preferred Stock\") automatically converted on a one-for-one basis into Common Stock upon the closing of the Issuer's initial public offering (the \"IPO\"), for no additional consideration. The shares of Preferred Stock have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series B Preferred Stock and Series C Preferred Stock (the \"Preferred Stock\") automatically converted on a one-for-one basis into Common Stock upon the closing of the Issuer's initial public offering (the \"IPO\"), for no additional consideration. The shares of Preferred Stock have no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"EPQ LLC, LFLU PS (\"LFLU\") is the direct beneficial owner of these shares."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F8","text":"EPIQ Capital Group, LLC (\"EPIQ\") may be deemed an indirect beneficial owner of 13,124,349 shares of Issuer's Common Stock, which are held by LFLU (3,754,084 shares), LCOVD (5,173,026 shares), SAFE (735,475 shares), and LTEST (3,461,764 shares)."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F9","text":"The reporting persons are EPIQ, Chad Boeding, LFLU, LCOVD, SAFE, and LTEST. EPIQ is the managing member of and LFLU, LCOVD, SAFE, and LTEST. Mr. Boeding is the CEO and Manager of EPIQ. EPIQ is filing this Form 4 on behalf of the reporting persons jointly, but not as a group. LFLU, LCOVD, SAFE, LTEST and Mr. Boeding each disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934 except to the extent of its or his pecuniary interest therein, if any. This report shall not be deemed an admission that any of the Reporting Persons is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3754084},"source":{"system":"sec-edgar","filing":"0001779453-21-000004","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1818376/000177945321000004/primary_doc.xml","form_type":"4"}},{"id":2872393,"issuer":{"id":115613,"kind":"organization","name":"Lucira Health, Inc.","symbol":"LHDX"},"owners":[{"id":95738,"kind":"organization","name":"EPIQ Capital Group, LLC","position":1,"cik":"0001779453","reported_name":"EPIQ Capital Group, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":121535,"kind":"organization","name":"EPQ LLC, LFLU PS","position":2,"cik":"0001798799","reported_name":"EPQ LLC, LFLU PS","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"<10% Owner"}},{"id":121536,"kind":"organization","name":"EPQ LLC, LCOVD PS","position":3,"cik":"0001818376","reported_name":"EPQ LLC, LCOVD PS","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":121537,"kind":"organization","name":"EPQ LLC, LCOVD SAFE PS","position":4,"cik":"0001833912","reported_name":"EPQ LLC, LCOVD SAFE PS","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"<10% Owner"}},{"id":121534,"kind":"organization","name":"EPQ LLC, LTEST PS","position":5,"cik":"0001841495","reported_name":"EPQ LLC, LTEST PS","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"<10% Owner"}},{"id":95739,"kind":"person","name":"Boeding Chad","position":6,"cik":"0001779451","reported_name":"Boeding Chad","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"CEO of 10% Owner"}}],"security":"Series B Convertible Preferred","published_at":"2021-02-09T18:39:06.000Z","date":"2021-02-05","kind":"exercise","acquired":false,"shares":32176,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series B Preferred Stock and Series C Preferred Stock (the \"Preferred Stock\") automatically converted on a one-for-one basis into Common Stock upon the closing of the Issuer's initial public offering (the \"IPO\"), for no additional consideration. The shares of Preferred Stock have no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series B Preferred Stock and Series C Preferred Stock (the \"Preferred Stock\") automatically converted on a one-for-one basis into Common Stock upon the closing of the Issuer's initial public offering (the \"IPO\"), for no additional consideration. The shares of Preferred Stock have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series B Preferred Stock and Series C Preferred Stock (the \"Preferred Stock\") automatically converted on a one-for-one basis into Common Stock upon the closing of the Issuer's initial public offering (the \"IPO\"), for no additional consideration. The shares of Preferred Stock have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series B Preferred Stock and Series C Preferred Stock (the \"Preferred Stock\") automatically converted on a one-for-one basis into Common Stock upon the closing of the Issuer's initial public offering (the \"IPO\"), for no additional consideration. The shares of Preferred Stock have no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Chad Boeding is the beneficial owner of these shares through a trust that he controls."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F9","text":"The reporting persons are EPIQ, Chad Boeding, LFLU, LCOVD, SAFE, and LTEST. EPIQ is the managing member of and LFLU, LCOVD, SAFE, and LTEST. Mr. Boeding is the CEO and Manager of EPIQ. EPIQ is filing this Form 4 on behalf of the reporting persons jointly, but not as a group. LFLU, LCOVD, SAFE, LTEST and Mr. Boeding each disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934 except to the extent of its or his pecuniary interest therein, if any. This report shall not be deemed an admission that any of the Reporting Persons is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":32176},"source":{"system":"sec-edgar","filing":"0001779453-21-000004","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1818376/000177945321000004/primary_doc.xml","form_type":"4"}},{"id":2872392,"issuer":{"id":115613,"kind":"organization","name":"Lucira Health, Inc.","symbol":"LHDX"},"owners":[{"id":95738,"kind":"organization","name":"EPIQ Capital Group, LLC","position":1,"cik":"0001779453","reported_name":"EPIQ Capital Group, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":121535,"kind":"organization","name":"EPQ LLC, LFLU PS","position":2,"cik":"0001798799","reported_name":"EPQ LLC, LFLU PS","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"<10% Owner"}},{"id":121536,"kind":"organization","name":"EPQ LLC, LCOVD PS","position":3,"cik":"0001818376","reported_name":"EPQ LLC, LCOVD PS","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":121537,"kind":"organization","name":"EPQ LLC, LCOVD SAFE PS","position":4,"cik":"0001833912","reported_name":"EPQ LLC, LCOVD SAFE PS","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"<10% Owner"}},{"id":121534,"kind":"organization","name":"EPQ LLC, LTEST PS","position":5,"cik":"0001841495","reported_name":"EPQ LLC, LTEST PS","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"<10% Owner"}},{"id":95739,"kind":"person","name":"Boeding Chad","position":6,"cik":"0001779451","reported_name":"Boeding Chad","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"CEO of 10% Owner"}}],"security":"Common Stock","published_at":"2021-02-09T18:39:06.000Z","date":"2021-02-05","kind":"purchase","acquired":true,"shares":3461764,"price":17,"value":58849988.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F7","text":"EPQ LLC, LTEST PS (\"LTEST\") is the direct beneficial owner of these shares."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F8","text":"EPIQ Capital Group, LLC (\"EPIQ\") may be deemed an indirect beneficial owner of 13,124,349 shares of Issuer's Common Stock, which are held by LFLU (3,754,084 shares), LCOVD (5,173,026 shares), SAFE (735,475 shares), and LTEST (3,461,764 shares)."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F9","text":"The reporting persons are EPIQ, Chad Boeding, LFLU, LCOVD, SAFE, and LTEST. EPIQ is the managing member of and LFLU, LCOVD, SAFE, and LTEST. Mr. Boeding is the CEO and Manager of EPIQ. EPIQ is filing this Form 4 on behalf of the reporting persons jointly, but not as a group. LFLU, LCOVD, SAFE, LTEST and Mr. Boeding each disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934 except to the extent of its or his pecuniary interest therein, if any. This report shall not be deemed an admission that any of the Reporting Persons is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose."}],"balance_after":3461764,"source":{"system":"sec-edgar","filing":"0001779453-21-000004","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1818376/000177945321000004/primary_doc.xml","form_type":"4"}},{"id":2872391,"issuer":{"id":115613,"kind":"organization","name":"Lucira Health, Inc.","symbol":"LHDX"},"owners":[{"id":95738,"kind":"organization","name":"EPIQ Capital Group, LLC","position":1,"cik":"0001779453","reported_name":"EPIQ Capital Group, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":121535,"kind":"organization","name":"EPQ LLC, LFLU PS","position":2,"cik":"0001798799","reported_name":"EPQ LLC, LFLU PS","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"<10% Owner"}},{"id":121536,"kind":"organization","name":"EPQ LLC, LCOVD PS","position":3,"cik":"0001818376","reported_name":"EPQ LLC, LCOVD PS","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":121537,"kind":"organization","name":"EPQ LLC, LCOVD SAFE PS","position":4,"cik":"0001833912","reported_name":"EPQ LLC, LCOVD SAFE PS","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"<10% Owner"}},{"id":121534,"kind":"organization","name":"EPQ LLC, LTEST PS","position":5,"cik":"0001841495","reported_name":"EPQ LLC, LTEST PS","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"<10% Owner"}},{"id":95739,"kind":"person","name":"Boeding Chad","position":6,"cik":"0001779451","reported_name":"Boeding Chad","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"CEO of 10% Owner"}}],"security":"Common Stock","published_at":"2021-02-09T18:39:06.000Z","date":"2021-02-05","kind":"exercise","acquired":true,"shares":735475,"price":17,"value":12503075.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The convertible promissory note automatically converted into shares of the Issuer's Common Stock upon the closing of the IPO."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F6","text":"EPQ LLC, LCOVD SAFE PS (\"SAFE\") is the direct beneficial owner of this shares."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F8","text":"EPIQ Capital Group, LLC (\"EPIQ\") may be deemed an indirect beneficial owner of 13,124,349 shares of Issuer's Common Stock, which are held by LFLU (3,754,084 shares), LCOVD (5,173,026 shares), SAFE (735,475 shares), and LTEST (3,461,764 shares)."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F9","text":"The reporting persons are EPIQ, Chad Boeding, LFLU, LCOVD, SAFE, and LTEST. EPIQ is the managing member of and LFLU, LCOVD, SAFE, and LTEST. Mr. Boeding is the CEO and Manager of EPIQ. EPIQ is filing this Form 4 on behalf of the reporting persons jointly, but not as a group. LFLU, LCOVD, SAFE, LTEST and Mr. Boeding each disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934 except to the extent of its or his pecuniary interest therein, if any. This report shall not be deemed an admission that any of the Reporting Persons is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose."}],"balance_after":735475,"source":{"system":"sec-edgar","filing":"0001779453-21-000004","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1818376/000177945321000004/primary_doc.xml","form_type":"4"}},{"id":2872390,"issuer":{"id":115613,"kind":"organization","name":"Lucira Health, Inc.","symbol":"LHDX"},"owners":[{"id":95738,"kind":"organization","name":"EPIQ Capital Group, LLC","position":1,"cik":"0001779453","reported_name":"EPIQ Capital Group, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":121535,"kind":"organization","name":"EPQ LLC, LFLU PS","position":2,"cik":"0001798799","reported_name":"EPQ LLC, LFLU PS","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"<10% Owner"}},{"id":121536,"kind":"organization","name":"EPQ LLC, LCOVD PS","position":3,"cik":"0001818376","reported_name":"EPQ LLC, LCOVD PS","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":121537,"kind":"organization","name":"EPQ LLC, LCOVD SAFE PS","position":4,"cik":"0001833912","reported_name":"EPQ LLC, LCOVD SAFE PS","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"<10% Owner"}},{"id":121534,"kind":"organization","name":"EPQ LLC, LTEST PS","position":5,"cik":"0001841495","reported_name":"EPQ LLC, LTEST PS","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"<10% Owner"}},{"id":95739,"kind":"person","name":"Boeding Chad","position":6,"cik":"0001779451","reported_name":"Boeding Chad","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"CEO of 10% Owner"}}],"security":"Common Stock","published_at":"2021-02-09T18:39:06.000Z","date":"2021-02-05","kind":"exercise","acquired":true,"shares":5173026,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series B Preferred Stock and Series C Preferred Stock (the \"Preferred Stock\") automatically converted on a one-for-one basis into Common Stock upon the closing of the Issuer's initial public offering (the \"IPO\"), for no additional consideration. The shares of Preferred Stock have no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"EPQ LLC, LCOVD PS (\"LCOVD\") is the direct beneficial owner of these shares."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F8","text":"EPIQ Capital Group, LLC (\"EPIQ\") may be deemed an indirect beneficial owner of 13,124,349 shares of Issuer's Common Stock, which are held by LFLU (3,754,084 shares), LCOVD (5,173,026 shares), SAFE (735,475 shares), and LTEST (3,461,764 shares)."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F9","text":"The reporting persons are EPIQ, Chad Boeding, LFLU, LCOVD, SAFE, and LTEST. EPIQ is the managing member of and LFLU, LCOVD, SAFE, and LTEST. Mr. Boeding is the CEO and Manager of EPIQ. EPIQ is filing this Form 4 on behalf of the reporting persons jointly, but not as a group. LFLU, LCOVD, SAFE, LTEST and Mr. Boeding each disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934 except to the extent of its or his pecuniary interest therein, if any. This report shall not be deemed an admission that any of the Reporting Persons is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose."}],"balance_after":5173026,"source":{"system":"sec-edgar","filing":"0001779453-21-000004","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1818376/000177945321000004/primary_doc.xml","form_type":"4"}},{"id":2872389,"issuer":{"id":115613,"kind":"organization","name":"Lucira Health, Inc.","symbol":"LHDX"},"owners":[{"id":95738,"kind":"organization","name":"EPIQ Capital Group, LLC","position":1,"cik":"0001779453","reported_name":"EPIQ Capital Group, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":121535,"kind":"organization","name":"EPQ LLC, LFLU PS","position":2,"cik":"0001798799","reported_name":"EPQ LLC, LFLU PS","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"<10% Owner"}},{"id":121536,"kind":"organization","name":"EPQ LLC, LCOVD PS","position":3,"cik":"0001818376","reported_name":"EPQ LLC, LCOVD PS","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":121537,"kind":"organization","name":"EPQ LLC, LCOVD SAFE PS","position":4,"cik":"0001833912","reported_name":"EPQ LLC, LCOVD SAFE PS","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"<10% Owner"}},{"id":121534,"kind":"organization","name":"EPQ LLC, LTEST PS","position":5,"cik":"0001841495","reported_name":"EPQ LLC, LTEST PS","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"<10% Owner"}},{"id":95739,"kind":"person","name":"Boeding Chad","position":6,"cik":"0001779451","reported_name":"Boeding Chad","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"CEO of 10% Owner"}}],"security":"Common Stock","published_at":"2021-02-09T18:39:06.000Z","date":"2021-02-05","kind":"exercise","acquired":true,"shares":3754084,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series B Preferred Stock and Series C Preferred Stock (the \"Preferred Stock\") automatically converted on a one-for-one basis into Common Stock upon the closing of the Issuer's initial public offering (the \"IPO\"), for no additional consideration. The shares of Preferred Stock have no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"EPQ LLC, LFLU PS (\"LFLU\") is the direct beneficial owner of these shares."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F8","text":"EPIQ Capital Group, LLC (\"EPIQ\") may be deemed an indirect beneficial owner of 13,124,349 shares of Issuer's Common Stock, which are held by LFLU (3,754,084 shares), LCOVD (5,173,026 shares), SAFE (735,475 shares), and LTEST (3,461,764 shares)."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F9","text":"The reporting persons are EPIQ, Chad Boeding, LFLU, LCOVD, SAFE, and LTEST. EPIQ is the managing member of and LFLU, LCOVD, SAFE, and LTEST. Mr. Boeding is the CEO and Manager of EPIQ. EPIQ is filing this Form 4 on behalf of the reporting persons jointly, but not as a group. LFLU, LCOVD, SAFE, LTEST and Mr. Boeding each disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934 except to the extent of its or his pecuniary interest therein, if any. This report shall not be deemed an admission that any of the Reporting Persons is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose."}],"balance_after":3754084,"source":{"system":"sec-edgar","filing":"0001779453-21-000004","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1818376/000177945321000004/primary_doc.xml","form_type":"4"}},{"id":2872388,"issuer":{"id":115613,"kind":"organization","name":"Lucira Health, Inc.","symbol":"LHDX"},"owners":[{"id":95738,"kind":"organization","name":"EPIQ Capital Group, LLC","position":1,"cik":"0001779453","reported_name":"EPIQ Capital Group, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":121535,"kind":"organization","name":"EPQ LLC, LFLU PS","position":2,"cik":"0001798799","reported_name":"EPQ LLC, LFLU PS","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"<10% Owner"}},{"id":121536,"kind":"organization","name":"EPQ LLC, LCOVD PS","position":3,"cik":"0001818376","reported_name":"EPQ LLC, LCOVD PS","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":121537,"kind":"organization","name":"EPQ LLC, LCOVD SAFE PS","position":4,"cik":"0001833912","reported_name":"EPQ LLC, LCOVD SAFE PS","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"<10% Owner"}},{"id":121534,"kind":"organization","name":"EPQ LLC, LTEST PS","position":5,"cik":"0001841495","reported_name":"EPQ LLC, LTEST PS","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"<10% Owner"}},{"id":95739,"kind":"person","name":"Boeding Chad","position":6,"cik":"0001779451","reported_name":"Boeding Chad","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"CEO of 10% Owner"}}],"security":"Common Stock","published_at":"2021-02-09T18:39:06.000Z","date":"2021-02-05","kind":"exercise","acquired":true,"shares":32176,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series B Preferred Stock and Series C Preferred Stock (the \"Preferred Stock\") automatically converted on a one-for-one basis into Common Stock upon the closing of the Issuer's initial public offering (the \"IPO\"), for no additional consideration. The shares of Preferred Stock have no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Chad Boeding is the beneficial owner of these shares through a trust that he controls."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F9","text":"The reporting persons are EPIQ, Chad Boeding, LFLU, LCOVD, SAFE, and LTEST. EPIQ is the managing member of and LFLU, LCOVD, SAFE, and LTEST. Mr. Boeding is the CEO and Manager of EPIQ. EPIQ is filing this Form 4 on behalf of the reporting persons jointly, but not as a group. LFLU, LCOVD, SAFE, LTEST and Mr. Boeding each disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934 except to the extent of its or his pecuniary interest therein, if any. This report shall not be deemed an admission that any of the Reporting Persons is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose."}],"balance_after":32176,"source":{"system":"sec-edgar","filing":"0001779453-21-000004","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818376/000177945321000004/primary_doc.xml","form_type":"4"}},{"id":3110732,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":95738,"kind":"organization","name":"EPIQ Capital Group, LLC","position":1,"cik":"0001779453","reported_name":"EPIQ Capital Group, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"IA/Managing Member of 10% Owne"}},{"id":95739,"kind":"person","name":"Boeding Chad","position":2,"cik":"0001779451","reported_name":"Boeding Chad","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Managing Member of Managing Me"}}],"security":"Common Stock","published_at":"2020-06-15T18:55:03.000Z","date":"2020-06-12","kind":"purchase","acquired":true,"shares":2440,"price":44.06,"value":107506.4,"ownership":{"direct":false,"nature":"By Mr. Boeding as Trustee of the Boeding Family Trust"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The reporting persons are EPIQ Capital Group, LLC (\"EPIQ\") and Chad Boeding. EPIQ is the investment adviser and managing member of EPQ LLC, CTYM PS (\"CTYM\") and CTEPQ Partners LLC (\"CTEPQ\"). Together CTYM and CTEPQ beneficially own more than 10% of the common stock of the issuer. Mr. Boeding is the Manager of EPIQ. EPIQ is filing this Form 4 on behalf of itself and Mr. Boeding jointly, but not as a group. CTYM, CTEPQ and Mr. Boeding disclaims beneficial ownership of the shares reported herein for purposes of Section 16 of the Securities Exchange Act of 1934 except to the extent of its or his pecuniary interest therein, if any. This report shall not be deemed an admission that any of the Reporting Persons is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose."}],"balance_after":2860967,"source":{"system":"sec-edgar","filing":"0001779453-20-000005","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1779451/000177945320000005/primary_doc.xml","form_type":"4"}},{"id":3110731,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":95738,"kind":"organization","name":"EPIQ Capital Group, LLC","position":1,"cik":"0001779453","reported_name":"EPIQ Capital Group, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"IA/Managing Member of 10% Owne"}},{"id":95739,"kind":"person","name":"Boeding Chad","position":2,"cik":"0001779451","reported_name":"Boeding Chad","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Managing Member of Managing Me"}}],"security":"Common Stock","published_at":"2020-06-15T18:55:03.000Z","date":"2020-06-11","kind":"purchase","acquired":true,"shares":6600,"price":44.32,"value":292512.0,"ownership":{"direct":false,"nature":"By Mr. Boeding as Trustee of the Boeding Family Trust"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The reporting persons are EPIQ Capital Group, LLC (\"EPIQ\") and Chad Boeding. EPIQ is the investment adviser and managing member of EPQ LLC, CTYM PS (\"CTYM\") and CTEPQ Partners LLC (\"CTEPQ\"). Together CTYM and CTEPQ beneficially own more than 10% of the common stock of the issuer. Mr. Boeding is the Manager of EPIQ. EPIQ is filing this Form 4 on behalf of itself and Mr. Boeding jointly, but not as a group. CTYM, CTEPQ and Mr. Boeding disclaims beneficial ownership of the shares reported herein for purposes of Section 16 of the Securities Exchange Act of 1934 except to the extent of its or his pecuniary interest therein, if any. This report shall not be deemed an admission that any of the Reporting Persons is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose."}],"balance_after":2858527,"source":{"system":"sec-edgar","filing":"0001779453-20-000005","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1779451/000177945320000005/primary_doc.xml","form_type":"4"}},{"id":3137494,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":95738,"kind":"organization","name":"EPIQ Capital Group, LLC","position":1,"cik":"0001779453","reported_name":"EPIQ Capital Group, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"IA/Managing Member of 10% Owne"}},{"id":95739,"kind":"person","name":"Boeding Chad","position":2,"cik":"0001779451","reported_name":"Boeding Chad","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Managing Member of 10% Owner"}}],"security":"Common Stock","published_at":"2020-05-22T18:03:14.000Z","date":"2020-05-22","kind":"purchase","acquired":true,"shares":2085,"price":55.9,"value":116551.5,"ownership":{"direct":false,"nature":"By Mr. Boeding as Trustee for the Boeding Family Trust"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The reporting persons are EPIQ Capital Group, LLC (\"EPIQ\") and Chad Boeding. EPIQ is the investment adviser and managing member of EPQ LLC, CTYM PS (\"CTYM\") and CTEPQ Partners LLC (\"CTEPQ\"). Together CTYM and CTEPQ beneficially own +10% of the common stock of the issuer. Mr. Boeding is the Managing Member of EPIQ. EPIQ is filing this Form 4 on behalf of itself and Mr. Boeding jointly, but not as a group, and each reporting person expressly disclaims membership in a group, within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934, as amended."}],"balance_after":2851927,"source":{"system":"sec-edgar","filing":"0001779453-20-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1779451/000177945320000002/primary_doc.xml","form_type":"4"}},{"id":3137493,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":95738,"kind":"organization","name":"EPIQ Capital Group, LLC","position":1,"cik":"0001779453","reported_name":"EPIQ Capital Group, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"IA/Managing Member of 10% Owne"}},{"id":95739,"kind":"person","name":"Boeding Chad","position":2,"cik":"0001779451","reported_name":"Boeding Chad","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Managing Member of 10% Owner"}}],"security":"Common Stock","published_at":"2020-05-22T18:03:14.000Z","date":"2020-05-21","kind":"purchase","acquired":true,"shares":520,"price":55.8,"value":29016.0,"ownership":{"direct":false,"nature":"By Mr. Boeding as Trustee for the Boeding Family Trust"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The reporting persons are EPIQ Capital Group, LLC (\"EPIQ\") and Chad Boeding. EPIQ is the investment adviser and managing member of EPQ LLC, CTYM PS (\"CTYM\") and CTEPQ Partners LLC (\"CTEPQ\"). Together CTYM and CTEPQ beneficially own +10% of the common stock of the issuer. Mr. Boeding is the Managing Member of EPIQ. EPIQ is filing this Form 4 on behalf of itself and Mr. Boeding jointly, but not as a group, and each reporting person expressly disclaims membership in a group, within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934, as amended."}],"balance_after":2849842,"source":{"system":"sec-edgar","filing":"0001779453-20-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1779451/000177945320000002/primary_doc.xml","form_type":"4"}},{"id":3137492,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":95738,"kind":"organization","name":"EPIQ Capital Group, LLC","position":1,"cik":"0001779453","reported_name":"EPIQ Capital Group, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"IA/Managing Member of 10% Owne"}},{"id":95739,"kind":"person","name":"Boeding Chad","position":2,"cik":"0001779451","reported_name":"Boeding Chad","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Managing Member of 10% Owner"}}],"security":"Common Stock","published_at":"2020-05-22T18:03:14.000Z","date":"2020-05-20","kind":"purchase","acquired":true,"shares":417,"price":57.22,"value":23860.74,"ownership":{"direct":false,"nature":"By Mr. Boeding as Trustee for the Boeding Family Trust"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The reporting persons are EPIQ Capital Group, LLC (\"EPIQ\") and Chad Boeding. EPIQ is the investment adviser and managing member of EPQ LLC, CTYM PS (\"CTYM\") and CTEPQ Partners LLC (\"CTEPQ\"). Together CTYM and CTEPQ beneficially own +10% of the common stock of the issuer. Mr. Boeding is the Managing Member of EPIQ. EPIQ is filing this Form 4 on behalf of itself and Mr. Boeding jointly, but not as a group, and each reporting person expressly disclaims membership in a group, within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934, as amended."}],"balance_after":2849322,"source":{"system":"sec-edgar","filing":"0001779453-20-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1779451/000177945320000002/primary_doc.xml","form_type":"4"}},{"id":3137491,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":95738,"kind":"organization","name":"EPIQ Capital Group, LLC","position":1,"cik":"0001779453","reported_name":"EPIQ Capital Group, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"IA/Managing Member of 10% Owne"}},{"id":95739,"kind":"person","name":"Boeding Chad","position":2,"cik":"0001779451","reported_name":"Boeding Chad","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Managing Member of 10% Owner"}}],"security":"Common Stock","published_at":"2020-05-22T18:03:14.000Z","date":"2020-05-20","kind":"purchase","acquired":true,"shares":5668,"price":58,"value":328744.0,"ownership":{"direct":false,"nature":"By Mr. Boeding as Trustee for the Boeding Family Trust"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The reporting persons are EPIQ Capital Group, LLC (\"EPIQ\") and Chad Boeding. EPIQ is the investment adviser and managing member of EPQ LLC, CTYM PS (\"CTYM\") and CTEPQ Partners LLC (\"CTEPQ\"). Together CTYM and CTEPQ beneficially own +10% of the common stock of the issuer. Mr. Boeding is the Managing Member of EPIQ. EPIQ is filing this Form 4 on behalf of itself and Mr. Boeding jointly, but not as a group, and each reporting person expressly disclaims membership in a group, within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934, as amended."}],"balance_after":2848905,"source":{"system":"sec-edgar","filing":"0001779453-20-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1779451/000177945320000002/primary_doc.xml","form_type":"4"}},{"id":3296803,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":95738,"kind":"organization","name":"EPIQ Capital Group, LLC","position":1,"cik":"0001779453","reported_name":"EPIQ Capital Group, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"IA/Managing Member of 10% Owne"}},{"id":95739,"kind":"person","name":"Boeding Chad","position":2,"cik":"0001779451","reported_name":"Boeding Chad","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Managing Member of Managing Me"}}],"security":"Common Stock","published_at":"2020-01-31T13:40:31.000Z","date":"2020-01-29","kind":"other","acquired":false,"shares":4338,"price":54.3,"value":235553.4,"ownership":{"direct":false,"nature":"By Mr. Boeding as Trustee for the Mitsou Peterson-Cushing 2019 Irrevocable Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were distributed in kind to the beneficiary of the Trust."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Shares distributed in kind. Reported price is the average of the high and low price for the day."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The reporting persons are EPIQ Capital Group, LLC (\"EPIQ\") and Chad Boeding. EPIQ is the investment adviser and managing member of EPQ LLC, CTYM PS (\"CTYM\") and CTEPQ Partners LLC (\"CTEPQ\"). Together CTYM and CTEPQ beneficially own +10% of the common stock of the issuer. Mr. Boeding is the Managing Member of EPIQ. EPIQ is filing this Form 4 on behalf of itself and Mr. Boeding jointly, but not as a group, and each reporting person expressly disclaims membership in a group, within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934, as amended."}],"balance_after":2843237,"source":{"system":"sec-edgar","filing":"0001779453-20-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1779451/000177945320000001/primary_doc.xml","form_type":"4"}},{"id":3356834,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":95738,"kind":"organization","name":"EPIQ Capital Group, LLC","position":1,"cik":"0001779453","reported_name":"EPIQ Capital Group, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"IA/Managing Member of 10% owne"}},{"id":95739,"kind":"person","name":"Boeding Chad","position":2,"cik":"0001779451","reported_name":"Boeding Chad","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Managing Member of Managing Me"}}],"security":"Common Stock","published_at":"2019-11-29T13:07:39.000Z","date":"2019-08-21","kind":"purchase","acquired":true,"shares":1635,"price":24.8685,"value":40659.9975,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Subsequent to an amended Form 3 filed 11/29/2019, the reporting persons are hereby amending Form 4 filed 8/21/2019 to amend the reported amount of securities beneficially owned for each transaction reported in Table 1."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The reporting persons are EPIQ Capital Group, LLC (\"EPIQ\") and Chad Boeding. EPIQ is the investment adviser and managing member of EPQ LLC, CTYM PS (\"CTYM\") and CTEPQ Partners LLC (\"CTEPQ\"). Together CTYM and CTEPQ beneficially own +10% of the common stock of the issuer. Mr. Boeding is the Managing Member of EPIQ. EPIQ is filing this Form 4 on behalf of itself and Mr. Boeding jointly, but not as a group, and each reporting person expressly disclaims membership in a group, within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934, as amended."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Beneficially owned directly by Mr. Boeding."}],"balance_after":2847575,"source":{"system":"sec-edgar","filing":"0001779453-19-000007","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1779451/000177945319000007/primary_doc.xml","form_type":"4/A","original_submission_date":"2019-08-21"}},{"id":3356833,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":95738,"kind":"organization","name":"EPIQ Capital Group, LLC","position":1,"cik":"0001779453","reported_name":"EPIQ Capital Group, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"IA/Managing Member of 10% owne"}},{"id":95739,"kind":"person","name":"Boeding Chad","position":2,"cik":"0001779451","reported_name":"Boeding Chad","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Managing Member of Managing Me"}}],"security":"Common Stock","published_at":"2019-11-29T13:07:39.000Z","date":"2019-08-21","kind":"purchase","acquired":true,"shares":420,"price":24.8685,"value":10444.77,"ownership":{"direct":false,"nature":"By Mr. Boeding as Trustee of Boeding Family Trust"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Subsequent to an amended Form 3 filed 11/29/2019, the reporting persons are hereby amending Form 4 filed 8/21/2019 to amend the reported amount of securities beneficially owned for each transaction reported in Table 1."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The reporting persons are EPIQ Capital Group, LLC (\"EPIQ\") and Chad Boeding. EPIQ is the investment adviser and managing member of EPQ LLC, CTYM PS (\"CTYM\") and CTEPQ Partners LLC (\"CTEPQ\"). Together CTYM and CTEPQ beneficially own +10% of the common stock of the issuer. Mr. Boeding is the Managing Member of EPIQ. EPIQ is filing this Form 4 on behalf of itself and Mr. Boeding jointly, but not as a group, and each reporting person expressly disclaims membership in a group, within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934, as amended."}],"balance_after":2845940,"source":{"system":"sec-edgar","filing":"0001779453-19-000007","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1779451/000177945319000007/primary_doc.xml","form_type":"4/A","original_submission_date":"2019-08-21"}},{"id":3356832,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":95738,"kind":"organization","name":"EPIQ Capital Group, LLC","position":1,"cik":"0001779453","reported_name":"EPIQ Capital Group, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"IA/Managing Member of 10% owne"}},{"id":95739,"kind":"person","name":"Boeding Chad","position":2,"cik":"0001779451","reported_name":"Boeding Chad","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Managing Member of Managing Me"}}],"security":"Common Stock","published_at":"2019-11-29T13:07:39.000Z","date":"2019-08-20","kind":"purchase","acquired":true,"shares":2310,"price":25.69,"value":59343.9,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Subsequent to an amended Form 3 filed 11/29/2019, the reporting persons are hereby amending Form 4 filed 8/21/2019 to amend the reported amount of securities beneficially owned for each transaction reported in Table 1."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The reporting persons are EPIQ Capital Group, LLC (\"EPIQ\") and Chad Boeding. EPIQ is the investment adviser and managing member of EPQ LLC, CTYM PS (\"CTYM\") and CTEPQ Partners LLC (\"CTEPQ\"). Together CTYM and CTEPQ beneficially own +10% of the common stock of the issuer. Mr. Boeding is the Managing Member of EPIQ. EPIQ is filing this Form 4 on behalf of itself and Mr. Boeding jointly, but not as a group, and each reporting person expressly disclaims membership in a group, within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934, as amended."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Beneficially owned directly by Mr. Boeding."}],"balance_after":2845520,"source":{"system":"sec-edgar","filing":"0001779453-19-000007","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1779451/000177945319000007/primary_doc.xml","form_type":"4/A","original_submission_date":"2019-08-21"}},{"id":3356831,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":95738,"kind":"organization","name":"EPIQ Capital Group, LLC","position":1,"cik":"0001779453","reported_name":"EPIQ Capital Group, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"IA/Managing Member of 10% owne"}},{"id":95739,"kind":"person","name":"Boeding Chad","position":2,"cik":"0001779451","reported_name":"Boeding Chad","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Managing Member of Managing Me"}}],"security":"Common Stock","published_at":"2019-11-29T13:07:39.000Z","date":"2019-08-20","kind":"purchase","acquired":true,"shares":600,"price":25.69,"value":15414.0,"ownership":{"direct":false,"nature":"By Mr. Boeding as Trustee for Boeding Family Trust"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Subsequent to an amended Form 3 filed 11/29/2019, the reporting persons are hereby amending Form 4 filed 8/21/2019 to amend the reported amount of securities beneficially owned for each transaction reported in Table 1."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The reporting persons are EPIQ Capital Group, LLC (\"EPIQ\") and Chad Boeding. EPIQ is the investment adviser and managing member of EPQ LLC, CTYM PS (\"CTYM\") and CTEPQ Partners LLC (\"CTEPQ\"). Together CTYM and CTEPQ beneficially own +10% of the common stock of the issuer. Mr. Boeding is the Managing Member of EPIQ. EPIQ is filing this Form 4 on behalf of itself and Mr. Boeding jointly, but not as a group, and each reporting person expressly disclaims membership in a group, within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934, as amended."}],"balance_after":2843210,"source":{"system":"sec-edgar","filing":"0001779453-19-000007","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1779451/000177945319000007/primary_doc.xml","form_type":"4/A","original_submission_date":"2019-08-21"}},{"id":3356771,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":95738,"kind":"organization","name":"EPIQ Capital Group, LLC","position":1,"cik":"0001779453","reported_name":"EPIQ Capital Group, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"IA/Managing Member of 10% owne"}},{"id":95739,"kind":"person","name":"Boeding Chad","position":2,"cik":"0001779451","reported_name":"Boeding Chad","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Managing Member of Managing Me"}}],"security":"Common Stock","published_at":"2019-11-29T12:59:11.000Z","date":"2019-08-19","kind":"purchase","acquired":true,"shares":2100,"price":26.4952,"value":55639.92,"ownership":{"direct":false,"nature":"By Mr. Boeding as Trustee of Boeding Family Trust"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Subsequent to an amended Form 3 filed 11/29/2019, the reporting persons are hereby amending Form 4 filed 8/19/2019 to amend the reported amount of securities beneficially owned for each transaction reported in Table 1."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The reporting persons are EPIQ Capital Group, LLC (\"EPIQ\") and Chad Boeding. EPIQ is the investment adviser and managing member of EPQ LLC, CTYM PS (\"CTYM\") and CTEPQ Partners LLC (\"CTEPQ\"). Together CTYM and CTEPQ beneficially own +10% of the common stock of the issuer. Mr. Boeding is the Managing Member of EPIQ. EPIQ is filing this Form 4 on behalf of itself and Mr. Boeding jointly, but not as a group, and each reporting person expressly disclaims membership in a group, within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934, as amended."}],"balance_after":2842610,"source":{"system":"sec-edgar","filing":"0001779453-19-000006","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1779451/000177945319000006/primary_doc.xml","form_type":"4/A","original_submission_date":"2019-08-19"}},{"id":3356770,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":95738,"kind":"organization","name":"EPIQ Capital Group, LLC","position":1,"cik":"0001779453","reported_name":"EPIQ Capital Group, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"IA/Managing Member of 10% owne"}},{"id":95739,"kind":"person","name":"Boeding Chad","position":2,"cik":"0001779451","reported_name":"Boeding Chad","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Managing Member of Managing Me"}}],"security":"Common Stock","published_at":"2019-11-29T12:59:11.000Z","date":"2019-08-16","kind":"purchase","acquired":true,"shares":700,"price":26.3714,"value":18459.98,"ownership":{"direct":false,"nature":"By Mr. Boeding as Trustee of Boeding Family Trust"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Subsequent to an amended Form 3 filed 11/29/2019, the reporting persons are hereby amending Form 4 filed 8/19/2019 to amend the reported amount of securities beneficially owned for each transaction reported in Table 1."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The reporting persons are EPIQ Capital Group, LLC (\"EPIQ\") and Chad Boeding. EPIQ is the investment adviser and managing member of EPQ LLC, CTYM PS (\"CTYM\") and CTEPQ Partners LLC (\"CTEPQ\"). Together CTYM and CTEPQ beneficially own +10% of the common stock of the issuer. Mr. Boeding is the Managing Member of EPIQ. EPIQ is filing this Form 4 on behalf of itself and Mr. Boeding jointly, but not as a group, and each reporting person expressly disclaims membership in a group, within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934, as amended."}],"balance_after":2840510,"source":{"system":"sec-edgar","filing":"0001779453-19-000006","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1779451/000177945319000006/primary_doc.xml","form_type":"4/A","original_submission_date":"2019-08-19"}},{"id":3356774,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":95738,"kind":"organization","name":"EPIQ Capital Group, LLC","position":1,"cik":"0001779453","reported_name":"EPIQ Capital Group, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"IA/Managing Member of 10% owne"}},{"id":95739,"kind":"person","name":"Boeding Chad","position":2,"cik":"0001779451","reported_name":"Boeding Chad","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Managing Member of Managing Me"}}],"security":"Common Stock","published_at":"2019-11-29T12:52:29.000Z","date":"2019-05-10","kind":"purchase","acquired":true,"shares":80,"price":27.05,"value":2164.0,"ownership":{"direct":false,"nature":"By Mr. Boeding as custodian for minor child"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Subsequent to an amended Form 3 filed 11/29/2019, the reporting persons are hereby amending Form 4 filed 6/14/2019 to amend the reported amount of securities beneficially owned for each transaction reported in Table 1."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The reporting persons are EPIQ Capital Group, LLC (\"EPIQ\") and Chad Boeding. EPIQ is the investment adviser and managing member of EPQ LLC, CTYM PS (\"CTYM\") and CTEPQ Partners LLC (\"CTEPQ\"). Together CTYM and CTEPQ beneficially own +10% of the common stock of the issuer. Mr. Boeding is the Managing Member of EPIQ. EPIQ is filing this Form 4 on behalf of itself and Mr. Boeding jointly, but not as a group, and each reporting person expressly disclaims membership in a group, within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934, as amended."}],"balance_after":2839810,"source":{"system":"sec-edgar","filing":"0001779453-19-000005","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1779451/000177945319000005/primary_doc.xml","form_type":"4/A","original_submission_date":"2019-06-14"}},{"id":3356773,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":95738,"kind":"organization","name":"EPIQ Capital Group, LLC","position":1,"cik":"0001779453","reported_name":"EPIQ Capital Group, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"IA/Managing Member of 10% owne"}},{"id":95739,"kind":"person","name":"Boeding Chad","position":2,"cik":"0001779451","reported_name":"Boeding Chad","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Managing Member of Managing Me"}}],"security":"Common Stock","published_at":"2019-11-29T12:52:29.000Z","date":"2019-05-10","kind":"purchase","acquired":true,"shares":4170,"price":27.58,"value":115008.6,"ownership":{"direct":false,"nature":"By Mr. Boeding as Trustee of Boeding Family Trust"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Subsequent to an amended Form 3 filed 11/29/2019, the reporting persons are hereby amending Form 4 filed 6/14/2019 to amend the reported amount of securities beneficially owned for each transaction reported in Table 1."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The reporting persons are EPIQ Capital Group, LLC (\"EPIQ\") and Chad Boeding. EPIQ is the investment adviser and managing member of EPQ LLC, CTYM PS (\"CTYM\") and CTEPQ Partners LLC (\"CTEPQ\"). Together CTYM and CTEPQ beneficially own +10% of the common stock of the issuer. Mr. Boeding is the Managing Member of EPIQ. EPIQ is filing this Form 4 on behalf of itself and Mr. Boeding jointly, but not as a group, and each reporting person expressly disclaims membership in a group, within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934, as amended."}],"balance_after":2839730,"source":{"system":"sec-edgar","filing":"0001779453-19-000005","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1779451/000177945319000005/primary_doc.xml","form_type":"4/A","original_submission_date":"2019-06-14"}},{"id":3356772,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":95738,"kind":"organization","name":"EPIQ Capital Group, LLC","position":1,"cik":"0001779453","reported_name":"EPIQ Capital Group, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"IA/Managing Member of 10% owne"}},{"id":95739,"kind":"person","name":"Boeding Chad","position":2,"cik":"0001779451","reported_name":"Boeding Chad","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Managing Member of Managing Me"}}],"security":"Common Stock","published_at":"2019-11-29T12:52:29.000Z","date":"2019-05-10","kind":"purchase","acquired":true,"shares":4350,"price":26.41,"value":114883.5,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Subsequent to an amended Form 3 filed 11/29/2019, the reporting persons are hereby amending Form 4 filed 6/14/2019 to amend the reported amount of securities beneficially owned for each transaction reported in Table 1."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The reporting persons are EPIQ Capital Group, LLC (\"EPIQ\") and Chad Boeding. EPIQ is the investment adviser and managing member of EPQ LLC, CTYM PS (\"CTYM\") and CTEPQ Partners LLC (\"CTEPQ\"). Together CTYM and CTEPQ beneficially own +10% of the common stock of the issuer. Mr. Boeding is the Managing Member of EPIQ. EPIQ is filing this Form 4 on behalf of itself and Mr. Boeding jointly, but not as a group, and each reporting person expressly disclaims membership in a group, within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934, as amended."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Beneficially owned directly by Mr. Boeding."}],"balance_after":2835560,"source":{"system":"sec-edgar","filing":"0001779453-19-000005","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1779451/000177945319000005/primary_doc.xml","form_type":"4/A","original_submission_date":"2019-06-14"}},{"id":3432224,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":95738,"kind":"organization","name":"EPIQ Capital Group, LLC","position":1,"cik":"0001779453","reported_name":"EPIQ Capital Group, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"IA/Managing Member 10% owner"}},{"id":95739,"kind":"person","name":"Boeding Chad","position":2,"cik":"0001779451","reported_name":"Boeding Chad","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Managing Member of IA"}}],"security":"Common Stock","published_at":"2019-08-21T16:54:59.000Z","date":"2019-08-21","kind":"purchase","acquired":true,"shares":1635,"price":24.8685,"value":40659.9975,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The reporting persons are EPIQ Capital Group, LLC (\"EPIQ\") and Chad Boeding. EPIQ is the investment adviser and managing member of EPQ LLC, CTYM PS (\"CTYM\") and CTEPQ Partners LLC (\"CTEPQ\"). Together CTYM and CTEPQ beneficially own +10% of the common stock of the issuer. Mr. Boeding is the Managing Member of EPIQ. EPIQ is filing this Form 4 on behalf of itself and Mr. Boeding jointly, but not as a group, and each reporting person expressly disclaims membership in a group, within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934, as amended."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Beneficially owned directly by Mr. Boeding."}],"balance_after":2834561,"source":{"system":"sec-edgar","filing":"0001779453-19-000003","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1779451/000177945319000003/primary_doc.xml","form_type":"4"}},{"id":3432223,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":95738,"kind":"organization","name":"EPIQ Capital Group, LLC","position":1,"cik":"0001779453","reported_name":"EPIQ Capital Group, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"IA/Managing Member 10% owner"}},{"id":95739,"kind":"person","name":"Boeding Chad","position":2,"cik":"0001779451","reported_name":"Boeding Chad","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Managing Member of IA"}}],"security":"Common Stock","published_at":"2019-08-21T16:54:59.000Z","date":"2019-08-21","kind":"purchase","acquired":true,"shares":420,"price":24.8685,"value":10444.77,"ownership":{"direct":false,"nature":"By Mr. Boeding as Trustee of Boeding Family Trust"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The reporting persons are EPIQ Capital Group, LLC (\"EPIQ\") and Chad Boeding. EPIQ is the investment adviser and managing member of EPQ LLC, CTYM PS (\"CTYM\") and CTEPQ Partners LLC (\"CTEPQ\"). Together CTYM and CTEPQ beneficially own +10% of the common stock of the issuer. Mr. Boeding is the Managing Member of EPIQ. EPIQ is filing this Form 4 on behalf of itself and Mr. Boeding jointly, but not as a group, and each reporting person expressly disclaims membership in a group, within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934, as amended."}],"balance_after":2832926,"source":{"system":"sec-edgar","filing":"0001779453-19-000003","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1779451/000177945319000003/primary_doc.xml","form_type":"4"}},{"id":3432222,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":95738,"kind":"organization","name":"EPIQ Capital Group, LLC","position":1,"cik":"0001779453","reported_name":"EPIQ Capital Group, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"IA/Managing Member 10% owner"}},{"id":95739,"kind":"person","name":"Boeding Chad","position":2,"cik":"0001779451","reported_name":"Boeding Chad","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Managing Member of IA"}}],"security":"Common Stock","published_at":"2019-08-21T16:54:59.000Z","date":"2019-08-20","kind":"purchase","acquired":true,"shares":2310,"price":25.69,"value":59343.9,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The reporting persons are EPIQ Capital Group, LLC (\"EPIQ\") and Chad Boeding. EPIQ is the investment adviser and managing member of EPQ LLC, CTYM PS (\"CTYM\") and CTEPQ Partners LLC (\"CTEPQ\"). Together CTYM and CTEPQ beneficially own +10% of the common stock of the issuer. Mr. Boeding is the Managing Member of EPIQ. EPIQ is filing this Form 4 on behalf of itself and Mr. Boeding jointly, but not as a group, and each reporting person expressly disclaims membership in a group, within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934, as amended."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Beneficially owned directly by Mr. Boeding."}],"balance_after":2832506,"source":{"system":"sec-edgar","filing":"0001779453-19-000003","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1779451/000177945319000003/primary_doc.xml","form_type":"4"}},{"id":3432221,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":95738,"kind":"organization","name":"EPIQ Capital Group, LLC","position":1,"cik":"0001779453","reported_name":"EPIQ Capital Group, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"IA/Managing Member 10% owner"}},{"id":95739,"kind":"person","name":"Boeding Chad","position":2,"cik":"0001779451","reported_name":"Boeding Chad","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Managing Member of IA"}}],"security":"Common Stock","published_at":"2019-08-21T16:54:59.000Z","date":"2019-08-20","kind":"purchase","acquired":true,"shares":600,"price":25.69,"value":15414.0,"ownership":{"direct":false,"nature":"By Mr. Boeding as Trustee for Boeding Family Trust"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The reporting persons are EPIQ Capital Group, LLC (\"EPIQ\") and Chad Boeding. EPIQ is the investment adviser and managing member of EPQ LLC, CTYM PS (\"CTYM\") and CTEPQ Partners LLC (\"CTEPQ\"). Together CTYM and CTEPQ beneficially own +10% of the common stock of the issuer. Mr. Boeding is the Managing Member of EPIQ. EPIQ is filing this Form 4 on behalf of itself and Mr. Boeding jointly, but not as a group, and each reporting person expressly disclaims membership in a group, within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934, as amended."}],"balance_after":2830196,"source":{"system":"sec-edgar","filing":"0001779453-19-000003","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1779451/000177945319000003/primary_doc.xml","form_type":"4"}},{"id":3434700,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":95738,"kind":"organization","name":"EPIQ Capital Group, LLC","position":1,"cik":"0001779453","reported_name":"EPIQ Capital Group, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"IA/Managing Member 10% owner"}},{"id":95739,"kind":"person","name":"Boeding Chad","position":2,"cik":"0001779451","reported_name":"Boeding Chad","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Managing Member of IA"}}],"security":"Common Stock","published_at":"2019-08-19T17:10:48.000Z","date":"2019-08-19","kind":"purchase","acquired":true,"shares":2100,"price":26.4952,"value":55639.92,"ownership":{"direct":false,"nature":"By Mr. Boeding as Trustee of Boeding Family Trust"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"1 The reporting persons are EPIQ Capital Group, LLC (\"EPIQ\") and Chad Boeding. EPIQ is the investment adviser and managing member of EPQ LLC, CTYM PS (\"CTYM\") and CTEPQ Partners LLC (\"CTEPQ\"). Together CTYM and CTEPQ beneficially own +10% of the common stock of the issuer. Mr. Boeding is the Managing Member of EPIQ. EPIQ is filing this Form 4 on behalf of itself and Mr. Boeding jointly, but not as a group, and each reporting person expressly disclaims membership in a group, within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934, as amended."}],"balance_after":2829596,"source":{"system":"sec-edgar","filing":"0001779451-19-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1779451/000177945119000001/primary_doc.xml","form_type":"4"}},{"id":3434699,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":95738,"kind":"organization","name":"EPIQ Capital Group, LLC","position":1,"cik":"0001779453","reported_name":"EPIQ Capital Group, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"IA/Managing Member 10% owner"}},{"id":95739,"kind":"person","name":"Boeding Chad","position":2,"cik":"0001779451","reported_name":"Boeding Chad","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Managing Member of IA"}}],"security":"Common Stock","published_at":"2019-08-19T17:10:48.000Z","date":"2019-08-16","kind":"purchase","acquired":true,"shares":700,"price":26.3714,"value":18459.98,"ownership":{"direct":false,"nature":"By Mr. Boeding as Trustee of Boeding Family Trust"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"1 The reporting persons are EPIQ Capital Group, LLC (\"EPIQ\") and Chad Boeding. EPIQ is the investment adviser and managing member of EPQ LLC, CTYM PS (\"CTYM\") and CTEPQ Partners LLC (\"CTEPQ\"). Together CTYM and CTEPQ beneficially own +10% of the common stock of the issuer. Mr. Boeding is the Managing Member of EPIQ. EPIQ is filing this Form 4 on behalf of itself and Mr. Boeding jointly, but not as a group, and each reporting person expressly disclaims membership in a group, within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934, as amended."}],"balance_after":2827496,"source":{"system":"sec-edgar","filing":"0001779451-19-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1779451/000177945119000001/primary_doc.xml","form_type":"4"}},{"id":3489774,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":95738,"kind":"organization","name":"EPIQ Capital Group, LLC","position":1,"cik":"0001779453","reported_name":"EPIQ Capital Group, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"IA/Managing Member 10% owner"}},{"id":95739,"kind":"person","name":"Boeding Chad","position":2,"cik":"0001779451","reported_name":"Boeding Chad","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-06-14T12:48:01.000Z","date":"2019-05-10","kind":"purchase","acquired":true,"shares":80,"price":27.05,"value":2164.0,"ownership":{"direct":false,"nature":"By Mr. Boeding as custodian for minor child"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The reporting persons are EPIQ Capital Group, LLC (\"EPIQ\") and Chad Boeding. EPIQ is the investment adviser and managing member of EPQ LLC, CTYM PS (\"CTYM\") and CTEPQ Partners LLC (\"CTEPQ\"). Together CTYM and CTEPQ beneficially own +10% of the common stock of the issuer. Mr. Boeding is the Managing Member of EPIQ. EPIQ is filing this Form 3 on behalf of itself and Mr. Boeding jointly, but not as a group, and each reporting person expressly disclaims membership in a group, within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934, as amended."}],"balance_after":2826796,"source":{"system":"sec-edgar","filing":"0001779453-19-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1779451/000177945319000002/primary_doc.xml","form_type":"4"}},{"id":3489773,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":95738,"kind":"organization","name":"EPIQ Capital Group, LLC","position":1,"cik":"0001779453","reported_name":"EPIQ Capital Group, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"IA/Managing Member 10% owner"}},{"id":95739,"kind":"person","name":"Boeding Chad","position":2,"cik":"0001779451","reported_name":"Boeding Chad","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-06-14T12:48:01.000Z","date":"2019-05-10","kind":"purchase","acquired":true,"shares":4170,"price":27.58,"value":115008.6,"ownership":{"direct":false,"nature":"By Mr. Boeding as Trustee of Boeding Family Trust"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The reporting persons are EPIQ Capital Group, LLC (\"EPIQ\") and Chad Boeding. EPIQ is the investment adviser and managing member of EPQ LLC, CTYM PS (\"CTYM\") and CTEPQ Partners LLC (\"CTEPQ\"). Together CTYM and CTEPQ beneficially own +10% of the common stock of the issuer. Mr. Boeding is the Managing Member of EPIQ. EPIQ is filing this Form 3 on behalf of itself and Mr. Boeding jointly, but not as a group, and each reporting person expressly disclaims membership in a group, within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934, as amended."}],"balance_after":2826716,"source":{"system":"sec-edgar","filing":"0001779453-19-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1779451/000177945319000002/primary_doc.xml","form_type":"4"}},{"id":3489772,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":95738,"kind":"organization","name":"EPIQ Capital Group, LLC","position":1,"cik":"0001779453","reported_name":"EPIQ Capital Group, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"IA/Managing Member 10% owner"}},{"id":95739,"kind":"person","name":"Boeding Chad","position":2,"cik":"0001779451","reported_name":"Boeding Chad","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-06-14T12:48:01.000Z","date":"2019-05-10","kind":"purchase","acquired":true,"shares":4350,"price":26.41,"value":114883.5,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The reporting persons are EPIQ Capital Group, LLC (\"EPIQ\") and Chad Boeding. EPIQ is the investment adviser and managing member of EPQ LLC, CTYM PS (\"CTYM\") and CTEPQ Partners LLC (\"CTEPQ\"). Together CTYM and CTEPQ beneficially own +10% of the common stock of the issuer. Mr. Boeding is the Managing Member of EPIQ. EPIQ is filing this Form 3 on behalf of itself and Mr. Boeding jointly, but not as a group, and each reporting person expressly disclaims membership in a group, within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934, as amended."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Beneficially owned directly by Mr. Boeding."}],"balance_after":2822546,"source":{"system":"sec-edgar","filing":"0001779453-19-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1779451/000177945319000002/primary_doc.xml","form_type":"4"}}]}